Xiu-Wu Bian Selected Research

N-Formylmethionine Leucyl-Phenylalanine

1/2008	Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
3/2007	[Effect of nordy on FPR function of malignant human glioma cell line U87].
4/2006	Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiu-Wu Bian Research Topics

Disease

74	Neoplasms (Cancer) 11/2022 - 10/2004
32	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 04/2006
32	Glioma (Gliomas) 10/2022 - 10/2004
18	Neoplasm Metastasis (Metastasis) 11/2022 - 12/2004
11	Carcinogenesis 03/2021 - 10/2004
8	Stomach Neoplasms (Stomach Cancer) 03/2021 - 01/2016
7	COVID-19 01/2022 - 07/2020
7	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2014
4	Brain Neoplasms (Brain Tumor) 11/2022 - 03/2012
4	Adenocarcinoma of Lung 01/2022 - 05/2013
4	Inflammation (Inflammations) 01/2021 - 03/2007
4	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 02/2012
3	Medulloblastoma 11/2022 - 03/2012
3	Hypoxia (Hypoxemia) 01/2022 - 08/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 04/2013
3	Lymphatic Metastasis 10/2016 - 12/2004
3	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 12/2004
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
2	Muscle Cramp (Cramp) 01/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 12/2020
2	Esophageal Squamous Cell Carcinoma 01/2020 - 04/2013
2	Ependymoma 01/2018 - 01/2016
2	Adenocarcinoma 04/2016 - 12/2004
2	Necrosis 01/2016 - 07/2012
2	Carcinoma (Carcinomatosis) 04/2012 - 12/2004
1	Rheumatoid Arthritis 01/2022
1	Starvation 01/2022
1	Heart Injuries 01/2022
1	Lung Injury 12/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
9	Pharmaceutical PreparationsIBA 01/2022 - 02/2008
8	Messenger RNA (mRNA)IBA 02/2022 - 03/2007
8	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2010
6	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2008
5	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 06/2017
5	LigandsIBA 01/2021 - 10/2004
5	Biological ProductsIBA 01/2019 - 12/2004
5	nordyIBA 10/2017 - 04/2006
4	CateninsIBA 03/2021 - 05/2013
4	Masoprocol (Actinex)FDA Link 10/2017 - 04/2006
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 04/2006
3	EnzymesIBA 01/2022 - 08/2013
3	Connexin 43 (Connexin43)IBA 08/2018 - 02/2012
3	Aldehyde DehydrogenaseIBA 03/2018 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 03/2007
3	CollagenIBA 01/2017 - 06/2010
3	Peptides (Polypeptides)IBA 01/2016 - 04/2006
3	N-Formylmethionine Leucyl-PhenylalanineIBA 01/2008 - 04/2006
2	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 11/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2016
2	HMGB1 Protein (HMG1)IBA 02/2022 - 11/2017
2	Metal-Organic FrameworksIBA 01/2022 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	ProteomeIBA 01/2022 - 06/2021
2	Disulfiram (Antabuse)FDA Link 01/2022 - 01/2017
2	MethyltransferasesIBA 01/2022 - 08/2016
2	IronIBA 01/2022 - 01/2022
2	CathelicidinsIBA 01/2021 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 10/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 10/2016
2	TensinsIBA 01/2019 - 10/2016
2	Tamoxifen FDA LinkGeneric 03/2018 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 01/2017
2	ibrutinibIBA 01/2018 - 11/2017
2	UbiquitinIBA 01/2017 - 01/2017
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2017 - 05/2009
2	Cadherins (E-Cadherin)IBA 06/2016 - 02/2012
2	plerixafor FDA Link 04/2016 - 09/2015
2	Chemokine ReceptorsIBA 04/2016 - 09/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 07/2010
2	Chemotactic FactorsIBA 07/2010 - 03/2007
2	Vincristine (Oncovin)FDA LinkGeneric 06/2008 - 12/2007
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	ApoferritinsIBA 01/2022
1	Glucose OxidaseIBA 01/2022
1	CytokinesIBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Immobilized EnzymesIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2022
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2022
1	Hydroxyl RadicalIBA 01/2022
1	Ribonuclease III (RNase III)IBA 01/2022
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	BI 6727IBA 12/2021
1	Therapeutic UsesIBA 12/2021

Therapy/Procedure

34	Therapeutics 01/2022 - 05/2009
11	Drug Therapy (Chemotherapy) 02/2022 - 08/2016
5	Immunotherapy 10/2022 - 06/2011
5	Radiotherapy 01/2022 - 04/2013
3	Lasers (Laser) 01/2022 - 10/2004